Skip to main content
SpringerLink
Log in

Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”

  • Letter to the Editor
  • Published:
American Journal of Cardiovascular Drugs Aims and scope Submit manuscript

The Original Article was published on 02 April 2024

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rangwala HS, Fatima H, Rangwala BS. Comment on: “Aspirin for the primary prevention of cardiovascular diseases in patients with chronic kidney disease: an updated meta-analysis”. Am J Cardiovasc Drugs (2024). https://doi.org/10.1007/s40256-024-00644-6

  2. Bellos S, Marinaki P, Lagiou V. Benetou, aspirin for the primary prevention of cardiovascular diseases in patients with chronic kidney disease: an updated meta-analysis. Am J Cardiovasc Drugs. 2024. https://doi.org/10.1007/S40256-024-00630-Y.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. https://doi.org/10.1016/J.JCLINEPI.2010.04.026.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 75, Mikras Asias str., 115 27, Athens, Greece

    Ioannis Bellos, Pagona Lagiou & Vassiliki Benetou

  2. Department of Nephrology and Renal Transplantation, School of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 75, Mikras Asias str., 115 27, Athens, Greece

    Ioannis Bellos & Smaragdi Marinaki

Authors
  1. Ioannis Bellos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Smaragdi Marinaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pagona Lagiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vassiliki Benetou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ioannis Bellos.

Ethics declarations

Funding

No external funding was used in the preparation of this reply.

Conflict of Interest

I.B., S.M., P.L., and V.B. declare that they have no potential conflicts of interest that might be relevant to the contents of this reply.

Authors’ Contributions

I.B.: conceptualization, data curation, analysis, methodology, and writing. S.M.: investigation, supervision, validation, reviewing, and editing. P.L.: supervision, validation, reviewing, and editing. V.B.: methodology, supervision, validation, reviewing, and editing.

Data Availability Statement

Not applicable.

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Code Availability

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellos, I., Marinaki, S., Lagiou, P. et al. Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”. Am J Cardiovasc Drugs (2024). https://doi.org/10.1007/s40256-024-00645-5

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40256-024-00645-5

Search

Navigation